What is galliprant for dogs?

What is galliprant for dogs?

When a beloved dog slows down, starts favoring a leg, or hesitates at the bottom of the stairs, the choices an owner makes about pain control can shape months or years of comfort and mobility. Galliprant is one option I often discuss with owners who want a targeted approach to osteoarthritis pain, especially when the usual drugs haven’t been well tolerated or when longer-term safety is a priority.

How Galliprant can improve life for dogs with osteoarthritis

Aging dogs commonly lose mobility in ways that are subtle at first: a shorter walk, reluctance to jump, or stiffness after rest. These changes are likely linked to joint inflammation from osteoarthritis, and managing that inflammation is often the difference between a dog that can still enjoy walks and one whose life is mostly napping. Owners who are weighing treatment choices are usually trying to balance two goals—improve activity and comfort now, while protecting long-term organ health for as many good months as possible. For dogs that previously had stomach upset, elevated kidney values, or other side effects on traditional nonsteroidal anti-inflammatory drugs, galliprant may present an alternative worth discussing with a veterinarian. I typically see owners prioritize preserving quality of life and safe daily function over more aggressive treatments that carry higher risk of side effects.

Galliprant in one sentence — a targeted arthritis medication for dogs

Galliprant is the brand name for the drug grapiprant. It is an oral tablet approved to control pain associated with osteoarthritis in dogs. Dosed by mouth once daily under veterinary direction, its main claimed benefit is targeted relief of pain and inflammation in affected joints. It is neither a steroid nor the classic type of NSAID that blocks the major enzymes that make prostaglandins; instead it acts on a specific pathway tied to joint pain, which is why many owners and clinicians think of it as a more selective option.

How Galliprant targets joint inflammation and relieves pain

To understand why galliprant may help without some of the effects of older drugs, it helps to know a little about the biology. When a joint is injured or worn, cells produce signaling chemicals such as prostaglandin E2 (PGE2) that promote pain and inflammation. Grapiprant blocks the EP4 receptor—the specific docking site that PGE2 uses to trigger the sensation of pain and many of the inflammatory changes in the joint. By preventing PGE2 from activating that receptor, galliprant is likely to reduce the pain signals and some local inflammation without blocking many other prostaglandin pathways that do protective work for the stomach and kidneys.

This is different from typical COX-inhibiting NSAIDs, which reduce the overall production of several prostaglandins by inhibiting cyclooxygenase enzymes. Because those drugs affect a broader set of prostaglandins, they can reduce pain effectively but also increase risk for gastrointestinal, kidney, or liver side effects in some dogs. Galliprant’s selectivity may mean fewer of those downstream effects for some patients, though it is not completely without risk. Owners should expect to give the medication consistently each day; some dogs may show improvement within a few days, while others may need a week or more to demonstrate clearer changes in activity and comfort.

Which dogs are best suited: when veterinarians prescribe Galliprant

Veterinary recommendation typically follows a careful diagnosis. For a dog with chronic osteoarthritis—identified by a consistent pattern of lameness, stiffness, reduced activity, and physical or radiographic evidence of joint changes—galliprant may be offered when daily pain control is needed. Factors that push me toward considering galliprant include older age, a history of GI sensitivity or adverse reactions to traditional NSAIDs, or concurrent conditions where minimizing broad prostaglandin suppression is desirable. For very active large-breed dogs or those with severe inflammation, a vet may combine strategies or choose a different drug depending on response.

Before starting, it’s important to consider the dog’s overall health. Pre-existing kidney, liver, or gastrointestinal disease alters the risk–benefit calculation and may lead your veterinarian to prefer one option over another or to recommend closer monitoring. If a dog is already on medications that raise concern—such as corticosteroids or another NSAID—those combinations are usually avoided because the risk of adverse effects can increase. I generally see galliprant chosen either as a first-line option in dogs where selective receptor blockade seems suitable, or as an alternative when traditional NSAIDs caused problems.

Side effects and warning signs — what to watch for

Like any medicine, galliprant has potential side effects. The most commonly reported are mild: vomiting, diarrhea, and a decrease in appetite. These often appear early and may resolve, but they require attention. Owners should be alert for more serious warning signs that demand immediate veterinary attention: bloody or black stools, protracted or severe vomiting, yellowing of the gums or eyes that suggests liver involvement, sudden weakness or collapse, or marked changes in thirst or urination that could suggest kidney problems. Any such signs should prompt stopping the medication and contacting your vet.

There are also important safety boundaries around combining drugs. Galliprant is not typically given together with other NSAIDs or corticosteroids because combining medicines that influence inflammation can raise the risk of gastrointestinal or renal harm. Pregnancy and lactation present additional cautions; because grapiprant’s effects in pregnant animals are not fully characterized, vets usually avoid it in breeding animals unless a clear reason and safety plan exist. For most dogs, a baseline set of blood tests—kidney and liver values plus a general blood count—is recommended before starting, and periodic rechecks may be suggested depending on age, concurrent disease, and clinical response.

If your vet prescribes Galliprant — practical steps for owners

  1. Obtain a veterinary diagnosis before starting any pain medication—accurate identification of osteoarthritis and its severity guides treatment choices.
  2. Follow the prescribed dose and timing exactly, and ask whether the tablet should be given with food; if an owner misses a dose, check with the clinic about whether to give it when remembered or wait until the next scheduled dose.
  3. Track daily signs: note mobility (walk length, steps climbed, ease getting up), appetite, stool quality, vomiting, and general behavior. Short, objective notes or a simple smartphone video can be priceless in follow-up visits.
  4. Arrange baseline bloodwork before starting and repeat testing as your veterinarian recommends—typically within a few weeks to months depending on the individual dog.
  5. Contact the veterinarian immediately for any red-flag symptoms such as bloody stools, yellowing of gums or eyes, severe vomiting, or sudden collapse; do not continue the medication without guidance if those appear.

Make your home arthritis‑friendly: simple adjustments that help

Medication is usually only one part of a successful plan. Small but consistent changes at home can significantly boost comfort and the effectiveness of any drug. Install secure ramps or pet stairs so a dog can reach favored spots without jumping; add non-slip mats or rugs where tile or hardwood makes traction difficult. Low-impact exercise—short, frequent walks and controlled play—helps maintain muscle tone and joint support without flaring pain. Weight management is often the single most important non-drug intervention; even a few pounds lost can reduce joint load and improve movement. Physical therapy, targeted stretching, and hydrotherapy can be very helpful for many dogs and are worth discussing with your veterinarian or a certified canine rehab practitioner.

Helpful, safe gear for arthritic dogs — what to choose

  • Orthopedic beds with supportive foam to reduce pressure on joints, and raised edges for easy head support.
  • Supportive harnesses and lifting slings that help owners assist the dog into cars or up stairs without straining the neck.
  • Ramps, pet stairs, and non-slip floor runners that allow confident movement between levels and onto furniture.
  • Elevated food and water bowls to reduce neck strain for dogs that feed with their head down, and secure carriers or seat restraints for safe transport to veterinary visits.

References and further reading

  • U.S. Food and Drug Administration. NADA 141-484 Approval Documents and Label for Galliprant (grapiprant) for Dogs.
  • Merck Veterinary Manual. Osteoarthritis in Dogs and Nonsteroidal Anti-Inflammatory Agents sections.
  • Rausch-Derra, et al., 2016. Clinical evaluation of grapiprant for the control of pain and inflammation in dogs with osteoarthritis. Journal of Veterinary Pharmacology and Therapeutics (clinical trial report).
  • Elanco. Galliprant (grapiprant) Prescribing Information and Product Literature.
  • American Veterinary Medical Association. Resources on pain management and multimodal care for canine osteoarthritis.
Rasa Žiema

Rasa is a veterinary doctor and a founder of Dogo.

Dogo was born after she has adopted her fearful and anxious dog – Ūdra. Her dog did not enjoy dog schools and Rasa took on the challenge to work herself.

Being a vet Rasa realised that many people and their dogs would benefit from dog training.